Literature DB >> 27430538

Decline in Child Hospitalization and Mortality After the Introduction of the 7-Valent Pneumococcal Conjugative Vaccine in Rwanda.

Janvier Rurangwa1, Nadine Rujeni2.   

Abstract

Pneumonia is a public health problem in the tropics, and the 7-valent pneumococcal conjugative vaccine (PCV-7) has been introduced in an effort to prevent the disease and therefore reduce childhood mortality. In Rwanda, PCV-7 was introduced in 2009, and we aimed to determine its impact on the rate of child hospitalization/mortality due to pneumonia. A retrospective survey was conducted on hospitalization rates and pediatric deaths between two periods, that is, before the introduction of PCV-7 (2007-2009) and after the introduction of PCV-7 (2010-2013) in Kabutare District Hospital. There was a 53% reduction in hospitalization, with a significant decline in in-hospital deaths between the two periods. There was also a significant correlation between vaccination coverage and decline in hospitalization rates between 2009 and 2013. We conclude that PCV-7 vaccine is associated with significant reduction in the rate of child hospitalization and mortality but more mechanistic studies are warranted to determine the immunological impact, especially in the context of coinfections and malnutrition. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27430538      PMCID: PMC5014278          DOI: 10.4269/ajtmh.15-0923

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Indirect population impact of universal PCV7 vaccination of children in a 2 + 1 schedule on the incidence of pneumonia morbidity in Kielce, Poland.

Authors:  M Patrzalek; P Gorynski; P Albrecht
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-16       Impact factor: 3.267

2.  The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.

Authors:  Chareeya Thanee; Chitsanu Pancharoen; Sasithorn Likitnukul; Voravich Luangwedchakarn; Pinklow Umrod; Chayapa Phasomsap; Tanakorn Apornpong; Thongsuai Chuanchareon; Oratai Butterworth; Thanyawee Puthanakit
Journal:  Vaccine       Date:  2011-07-03       Impact factor: 3.641

Review 3.  Community-acquired pneumonia in HIV-infected children: a global perspective.

Authors:  D M Gray; H J Zar
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

4.  Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.

Authors:  María Catalina Pírez; Gabriela Algorta; Alejandra Cedrés; Helena Sobrero; Adriana Varela; Gustavo Giachetto; Alicia Montano
Journal:  Pediatr Infect Dis J       Date:  2011-08       Impact factor: 2.129

5.  Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Authors:  Mark J Abzug; Stephen I Pelton; Lin-Ye Song; Terence Fenton; Myron J Levin; Sharon A Nachman; William Borkowsky; Howard M Rosenblatt; John F Marcinak; Arry Dieudonne; Elaine J Abrams; Indu Pathak
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

Review 6.  Antibiotics for community-acquired pneumonia in children.

Authors:  Rakesh Lodha; Sushil K Kabra; Ravindra M Pandey
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

7.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

8.  Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda.

Authors:  Agnes Binagwaho; Elisabetta Pegurri; Peter C Drobac; Placidie Mugwaneza; Sara N Stulac; Claire M Wagner; Corine Karema; Landry Tsague
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Global control of pneumococcal infections by pneumococcal vaccines.

Authors:  Kazunori Oishi; Kazuyo Tamura; Yukihiro Akeda
Journal:  Trop Med Health       Date:  2014-06

Review 10.  Viral pneumonia.

Authors:  Olli Ruuskanen; Elina Lahti; Lance C Jennings; David R Murdoch
Journal:  Lancet       Date:  2011-03-22       Impact factor: 79.321

View more
  3 in total

1.  Predictors of post neonatal mortality in Western Kenya: a cohort study.

Authors:  Grace Kaguthi; Videlis Nduba; Martien Wilhelm Borgdorff; Suzanne Verver
Journal:  Pan Afr Med J       Date:  2018-10-15

2.  Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh.

Authors:  Abdullah H Baqui; Eric D McCollum; Arif Mahmud; Arunangshu Roy; Nabidul H Chowdhury; Iftekhar Rafiqullah; Syed Jafar Raza Rizvi; Nazma Begum; Dipak K Mitra; Rasheda Khanam; Meagan Harrison; Salahuddin Ahmed; Md Hasanuzzaman; Hafizur Rahman; Maksuda Islam; Zabed B Ahmed; Md Abdul Quaiyum; Alain Koffi; Nicole Simmons; William Checkley; Lawrence H Moulton; Mathuram Santosham; Samir K Saha
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

3.  Development and application of a hybrid implementation research framework to understand success in reducing under-5 mortality in Rwanda.

Authors:  Lisa R Hirschhorn; Miriam Frisch; Jovial Thomas Ntawukuriryayo; Amelia VanderZanden; Kateri Donahoe; Kedest Mathewos; Felix Sayinzoga; Agnes Binagwaho
Journal:  Gates Open Res       Date:  2021-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.